• Issue

    Thoracic Cancer: Volume 11, Issue 1

    1-202
    January 2020
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 1-2
  • First Published: January 2020

EDITORIALS

Open Access

Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy

Weixian Hu, 
  • Pages: 3-5
  • First Published: 12 November 2019
Open Access

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells

Liyi Zhang, 
  • Pages: 6-7
  • First Published: 27 November 2019

ORIGINAL ARTICLES

Open Access

A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer

Keke Nie,  Zhen Zhang,  Yunhong You,  Xingjun Zhuang,  Chunling Zhang,  Youxin Ji, 
  • Pages: 8-14
  • First Published: 14 November 2019
Open Access

Retreatment with anti-PD-1 antibody in non-small cell lung cancer patients previously treated with anti-PD-L1 antibody

Kohei Fujita,  Yuki Yamamoto,  Osamu Kanai,  Misato Okamura,  Masayuki Hashimoto,  Koichi Nakatani,  Satoru Sawai,  Tadashi Mio, 
  • Pages: 15-18
  • First Published: 07 November 2019
Open Access

Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients

Ji Hyun Kim,  Shin Yup Lee,  Jin Eun Choi,  Sook Kyung Do,  Jang Hyuck Lee,  Mi Jeong Hong,  Hyo-Gyoung Kang,  Won Kee Lee,  Kyung Min Shin,  Ji Yun Jeong,  Sun Ha Choi,  Yong Hoon Lee,  Hyewon Seo,  Seung Soo Yoo,  Jaehee Lee,  Seung Ick Cha,  Chang Ho Kim,  Jae Yong Park, 
  • Pages: 19-28
  • First Published: 05 November 2019
Open Access

Circulating plasma lncRNAs as novel markers of EGFR mutation status and monitors of epidermal growth factor receptor-tyrosine kinase inhibitor therapy

Panpan Lv,  Shaoxing Yang,  Wenjing Liu,  Haifeng Qin,  Xiuhua Tang,  Fangfang Wu,  Zeyuan Liu,  Hongjun Gao,  Xiaoqing Liu, 
  • Pages: 29-40
  • First Published: 05 November 2019
Open Access

Upregulation of E-cadherin in bronchoalveolar lavage fluid-derived exosomes in patients with lung cancer

Ying Zhang,  Ziyu Liu,  Shanyu Li,  Manning Wang,  Dayou Dai,  Hongyu Jing,  Lingyun Liu, 
  • Pages: 41-47
  • First Published: 06 November 2019
Open Access

Ultrasound as a replacement for physical examination in clinical staging of axillary lymph nodes in breast cancer patients

Xue Chen,  Xiaoting Li,  Zhaoqing Fan,  Jinfeng Li,  Yuntao Xie,  Tianfeng Wang,  Tao Ouyang, 
  • Pages: 48-54
  • First Published: 11 November 2019
Open Access

MiR-563 restrains cell proliferation via targeting LIN28B in human lung cancer

Xuefei Zhang,  Mo Li,  Ge Sun,  Yu Bai,  Desheng Lv,  Changhong Liu, 
  • Pages: 55-61
  • First Published: 25 November 2019
Open Access

Geriatric Nutritional Risk Index as a prognostic marker in patients with extensive-stage disease small cell lung cancer: Results from a randomized controlled trial

Gyeong-Won Lee,  Se-Il Go,  Dong-Wan Kim,  Hoon-Gu Kim,  Joo-Hang Kim,  Ho Jung An,  Joung Soon Jang,  Bong-Seog Kim,  Seokyung Hahn,  Dae Seog Heo, 
  • Pages: 62-71
  • First Published: 10 November 2019
Open Access

Intraoperative localization of small pulmonary nodules to assist surgical resection: A novel approach using a surgical navigation puncture robot system

Gang Zhou,  Xiangqian Chen,  Baolong Niu,  Yadong Yan,  Fan Shao,  Yubo Fan,  Yu Wang, 
  • Pages: 72-81
  • First Published: 26 November 2019
Open Access

LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro

Yin Tang,  Ping Yang,  Yunfeng Zhu,  Yong Su, 
  • Pages: 82-94
  • First Published: 19 November 2019
Open Access

Copy number variation in plasma as a tool for lung cancer prediction using Extreme Gradient Boosting (XGBoost) classifier

Daping Yu,  Zhidong Liu,  Chongyu Su,  Yi Han,  XinChun Duan,  Rui Zhang,  Xiaoshuang Liu,  Yang Yang,  Shaofa Xu, 
  • Pages: 95-102
  • First Published: 06 November 2019
Open Access

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients

Ying Ding,  Lihua Zhang,  Lingchuan Guo,  Chunyan Wu,  Jianhua Zhou,  Yongchun Zhou,  Jie Ma,  Xiao Li,  Pan Ji,  Ming Wang,  Weidong Zhu,  Chenxi Shi,  Sanen Li,  Wei Wu,  Wei Zhu,  Desheng Xiao,  Chunyan Fu,  Qiuyan He,  Rui Sun,  Xinru Mao,  Analyn Lizaso,  Bing Li,  Han Han-Zhang,  Zhihong Zhang, 
  • Pages: 103-112
  • First Published: 06 November 2019
Open Access

Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy

Yao-Hung Kuo,  Hsin-Yuan Fang,  Yu-Sen Lin,  Ming-Yu Lein,  Chi-Ying Yang,  Shih-Chi Ho,  Chia-Chin Li,  Chun-Ru Chien, 
  • Pages: 113-119
  • First Published: 19 November 2019
Open Access

Prognostic impact of CD34 and SMA in cancer-associated fibroblasts in stage I–III NSCLC

Arik Bernard Schulze,  Lars Henning Schmidt,  Birthe Heitkötter,  Sebastian Huss,  Michael Mohr,  Alessandro Marra,  Ludger Hillejan,  Dennis Görlich,  Peter J. Barth,  Jan Rehkämper,  Georg Evers, 
  • Pages: 120-129
  • First Published: 24 November 2019
Open Access

The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance

Zhe Wang,  Jingze Zhang,  Minghuan Li,  Li Kong,  Jinming Yu, 
  • Pages: 130-139
  • First Published: 21 November 2019
Open Access

Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation

Daisuke Hayakawa,  Fumiyuki Takahashi,  Yoichiro Mitsuishi,  Ken Tajima,  Moulid Hidayat,  Wira Winardi,  Hiroaki Ihara,  Koichiro Kanamori,  Naohisa Matsumoto,  Tetsuhiko Asao,  Ryo Ko,  Takehito Shukuya,  Kazuya Takamochi,  Takuo Hayashi,  Yoshiyuki Suehara,  Ikuko Takeda Nakamura,  Toshihide Ueno,  Shinji Kohsaka,  Hiroyuki Mano,  Kazuhisa Takahashi, 
  • Pages: 140-149
  • First Published: 22 November 2019
Open Access

Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients' prognosis

Wenjun Du,  Juan Sun,  Jundong Gu,  Shiwu Zhang,  Tao Zhang, 
  • Pages: 150-155
  • First Published: 05 November 2019
Open Access

Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance

Ran Xiong,  Xiang-xiang Sun,  Han-ran Wu,  Guang-wen Xu,  Gao-xiang Wang,  Xiao-hui Sun,  Mei-qing Xu,  Ming-ran Xie, 
  • Pages: 156-165
  • First Published: 27 November 2019

CASE REPORTS

Open Access

Mixed-type primary germ cell tumor of the mediastinum in a young adult male with a sudden life threatening condition: A case report

Tadashi Sakane,  Katsuhiro Okuda,  Takayuki Murase,  Takuya Watanabe,  Risa Oda,  Tsutomu Tatematsu,  Keisuke Yokota,  Hiroshi Haneda,  Hiroshi Inagaki,  Ryoichi Nakanishi, 
  • Pages: 166-169
  • First Published: 06 November 2019
Open Access

Mediastinal venolymphatic malformations mimicking thymic carcinoma

Min Kyun Kang,  Do Kyun Kang,  Youn-Ho Hwang,  Ji Yeon Kim, 
  • Pages: 170-172
  • First Published: 19 November 2019
Open Access

Metastatic meningeal carcinomatosis from lung cancer: Report of a rare case

Hui Liu,  Li Liu,  Xiaochen Zhang,  Song Jin, 
  • Pages: 173-175
  • First Published: 17 November 2019
Open Access

Sequential ALK inhibitor treatment benefits patient with leptomeningeal metastasis harboring non-EML4-ALK rearrangements detected from cerebrospinal fluid: A case report

Zhaona Li,  Pupu Li,  Bing Yan,  Qiongqiong Gao,  Xiangli Jiang,  Zhongli Zhan,  Qingna Yan,  Analyn Lizaso,  Chun Huang, 
  • Pages: 176-180
  • First Published: 25 November 2019

CLINICAL GUIDELINES

Open Access

Clinical application of photodynamic therapy for malignant airway tumors in China

Faguang Jin,  Hongwu Wang,  Qiang Li,  Chong Bai,  Yiming Zeng,  Guoxiang Lai,  Shuliang Guo,  Xing Gu,  Wangping Li,  Haitao Zhang, 
  • Pages: 181-190
  • First Published: 24 November 2019
Open Access

Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis

Hanping Wang,  Xiaoxiao Guo,  Jiaxin Zhou,  Yue Li,  Lian Duan,  Xiaoyan Si,  Li Zhang,  Xiaowei Liu,  Mengzhao Wang,  Juhong Shi,  Li Zhang, 
  • Pages: 191-197
  • First Published: 24 November 2019
Open Access

Management of immune checkpoint inhibitor-related rheumatic adverse events

Jiaxin Zhou,  Hanping Wang,  Xiaoxiao Guo,  Qian Wang,  Lian Duan,  Xiaoyan Si,  Li Zhang,  Xiaowei Liu,  Yue Li,  Wen Zhang,  Li Zhang, 
  • Pages: 198-202
  • First Published: 24 November 2019